Celldex Therapeutics (CLDX) Long-Term Debt Issuances (2010 - 2013)

Celldex Therapeutics' Long-Term Debt Issuances history runs 4 years deep, the most recent figure standing at $428000.0 for Q4 2013.

• In Q4 2013, Long-Term Debt Issuances rose 2957.14% year-over-year to $428000.0; the TTM figure through Dec 2020 stood at $443000.0 (changed N/A YoY), while the FY2020 annual figure was $3.0 million, changed N/A from the prior year.
• Long-Term Debt Issuances for Q4 2013 stood at $428000.0, up from $15000.0 in the prior quarter.
• The five-year high for Long-Term Debt Issuances was $4.9 million in Q3 2011, with the low at -$1.3 million in Q2 2012.
• The 4-year median for Long-Term Debt Issuances is $15000.0 (2012), against an average of $433076.9.
• The sharpest annual moves came in 2011 and 2012: Long-Term Debt Issuances surged 9590.2% in 2011, then sank 11250.0% in 2012.
• Celldex Therapeutics' Long-Term Debt Issuances stood at $52000.0 in 2010, then jumped by 9403.85% to $4.9 million in 2011, then sank by 99.72% to $14000.0 in 2012, then soared by 2957.14% to $428000.0 in 2013.
• Business Quant data shows CLDX's Long-Term Debt Issuances at $428000.0 in Q4 2013, $15000.0 in Q3 2013, and $14000.0 in Q2 2013.